Protalix BioTherapeutics, Inc. Retained Earnings
Protalix BioTherapeutics, Inc. (PLX) had Retained Earnings of -$385.00 million as of 2025-12-31, per its 10-K filed 2026-03-18.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-03-18
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$385.00M.
- 2024-12-31: Retained Earnings (Accumulated Deficit) -$378.39M.
- 2023-12-31: Retained Earnings (Accumulated Deficit) -$381.55M.
- 2022-12-31: Retained Earnings (Accumulated Deficit) -$389.86M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2025-12-31 | -$385.00M 10-K · filed 2026-03-18 | |
| 2024-12-31 | -$378.39M 10-K · filed 2026-03-18 | |
| 2023-12-31 | -$381.55M 10-K · filed 2025-03-17 | |
| 2022-12-31 | -$389.86M 10-K · filed 2024-03-14 | |
| 2021-12-31 | -$374.93M 10-K · filed 2023-02-27 | |
| 2020-12-31 | -$347.35M 10-K · filed 2022-03-31 | |
| 2019-12-31 | -$340.83M 10-K · filed 2021-03-30 | |
| 2019-09-30 | $341.00M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $337.60M 10-Q · filed 2019-08-08 | |
| 2018-12-31 | -$322.55M 10-K · filed 2020-03-12 | |
| 2017-12-31 | -$296.10M 10-Q · filed 2019-03-18 | -$297.93M 10-K · filed 2018-03-06 |
| 2016-12-31 | -$212.66M 10-K · filed 2018-03-06 | |
| 2015-12-31 | -$183.29M 10-K · filed 2017-03-16 | |
| 2014-12-31 | -$241.33M 10-K · filed 2016-03-08 | |
| 2013-12-31 | -$211.38M 10-K · filed 2015-03-12 | |
| 2012-12-31 | -$183.59M 10-K · filed 2014-03-13 | |
| 2011-12-31 | -$171.98M 10-K · filed 2013-02-28 | |
| 2010-12-31 | -$135.45M 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |